TrialGynecologic oncology2012

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.

David S Alberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.